<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is a major cause of <z:hpo ids='HP_0011420'>death</z:hpo> in Japan, where it accounts for the largest number of <z:hpo ids='HP_0011420'>deaths</z:hpo> from malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> in women and the third largest number in men </plain></SENT>
<SENT sid="1" pm="."><plain>Many new treatment methods have been developed over the last few decades </plain></SENT>
<SENT sid="2" pm="."><plain>The Japanese Society for <z:e sem="disease" ids="C0007102" disease_type="Neoplastic Process" abbrv="">Cancer of the Colon</z:e> and Rectum (JSCCR) guidelines 2010 for the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (JSCCR Guidelines 2010) have been prepared to show standard treatment strategies for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, to eliminate disparities among institutions in terms of treatment, to eliminate unnecessary treatment and insufficient treatment, and to deepen mutual understanding between health-care professionals and patients by making these Guidelines available to the general public </plain></SENT>
<SENT sid="3" pm="."><plain>These Guidelines have been prepared by consensuses reached by the JSCCR Guideline Committee, based on a careful review of the evidence retrieved by literature searches and in view of the medical health insurance system and actual clinical practice settings in Japan </plain></SENT>
<SENT sid="4" pm="."><plain>Therefore, these Guidelines can be used as a tool for treating <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in actual clinical practice settings </plain></SENT>
<SENT sid="5" pm="."><plain>More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient </plain></SENT>
<SENT sid="6" pm="."><plain>As a result of the discussions held by the Guideline Committee, controversial issues were selected as Clinical Questions, and recommendations were made </plain></SENT>
<SENT sid="7" pm="."><plain>Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories based on the consensus reached by the Guideline Committee members </plain></SENT>
<SENT sid="8" pm="."><plain>Here we present the English version of the JSCCR Guidelines 2010 </plain></SENT>
</text></document>